Full-Time

Director – Global Scientific Communications

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior

Cambridge, MA, USA

70% in-office structure.

Category
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • PharmD/PhD with 5+ years or BSc/MSc in life sciences with 8+ years of experience in medical communications within the pharmaceutical or biotech industry.
  • Proven ability to lead and influence cross-functional teams without direct authority, driving strategic initiatives globally.
  • Experience utilizing digital platforms to optimize content delivery and stakeholder engagement.
  • Demonstrated ability to translate complex scientific data into clear, impactful messages for diverse external audiences, including healthcare professionals, regulatory bodies, and key opinion leaders.
  • Hands-on experience managing the MRC process and ensuring global compliance with varying regulatory requirements across different regions.
  • Exceptional verbal and written communication skills, with experience guiding teams on scientific communication best practices, even without direct reporting lines.
  • Proven ability to lead and influence cross-functional teams globally, co-creating strategies with local teams to ensure effective execution of global strategies.
Responsibilities
  • Collaborate closely with internal stakeholders, including clinical, commercial, and regulatory teams, to develop and execute strategic scientific communication plans that align with Moderna’s business objectives and the Global Medical Affairs Plan (GMAP).
  • Lead the translation of complex scientific data into impactful, globally consistent narratives that are clear, relevant and adaptable for external audiences such as healthcare professionals, regulatory bodies, and key opinion leaders in different regions.
  • Lead cross-functional teams globally, ensuring scientific messaging supports the broader global product strategy, complies with global regulatory requirements, and addresses local market dynamics.
  • Leverage digital tools and platforms to optimize content delivery, enhance stakeholder engagement, and ensure messages reach the right audiences through the most effective channels.
  • Oversee the creation and submission of scientific materials through the MRC process, ensuring timely updates, regulatory compliance, and global consistency across multiple therapeutic areas.
  • Mentor global and local teams on effective scientific communication strategies, fostering a collaborative approach that supports global alignment with local execution.
  • Lead the development of content for scientific symposia, conferences, and other key scientific forums, ensuring consistency in messaging and alignment with Moderna’s scientific leadership and strategic goals.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?